Established in Chicago, Illinois, Goldfinch is a US-based, family- and minority-owned asset management firm. We invest in private equity and venture capital funds and directly own and operate businesses alongside our world-class network of experienced investors and operators.
Over two decades, our family built and scaled Nexus Pharmaceuticals into a world-class pharmaceutical manufacturing business. Today, we bring that same passion and expertise across biotech, operations, real estate, and business development to every venture we pursue.
We apply family business principles to everything we do. We’ve been family from our genesis and have no intention of deviating. Our sophistication, people, processes, and technology are on par with the top players in the financial market, and our competitive edge is that we can see the entire market at a birds-eye view.
A biopharmaceutical company focused on the development of treatment for rare diseases. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL).
A U.S.-based, family-owned, minority-led pharmaceutical manufacturer founded in 2003.
A private investment company focused on real estate, sports, entertainment, consumer brands, and select small companies.
Interested in learning more or partnering with Goldfinch? We’d love to chat.